EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Muscle Strength and Power Changes With Gender‐Affirming Hormone Therapy

Mathilde Kamp Nørlund, Jakob Lindberg Nielsen, Marianne Skovsager Andersen, Rikke Hjortebjerg, Laust Frisenberg Buhl, Anne Pernille Hermann, Camilla Viola Buskbjerg Palm, Tine Taulbjerg Kristensen, Jan Frystyk, Per Aagaard, Jonas Mathiesen, Dorte Glintborg und 1 weitere

Andrology · 2026-10 · 14 (7) · 2138-2149

DOI: 10.1111/andr.70132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, online erschienen am 10.10.2025. Verfasst von Mathilde Kamp Nørlund und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Muscle Strength, Transgender Persons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Body Identity Clinic (BIC) Frontline Center Odense University Hospital, Pre-graduate Fund Odense University Hospital, Danish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgen receptors are highly expressed in upper body muscles, but changes in maximal muscle strength and power in major upper body muscles have not been investigated during gender‐affirming hormone therapy (GAHT).

Objective

To assess prospective changes in maximal muscle strength and muscle power from before and after 1 year of GAHT. Design and Methods Clinical prospective study in 92 transgender persons: 26 transmasculine treatment‐naïve (TransM_naïve), 27 transmasculine treatment‐ongoing (TransM_ongoing), 29 transfeminine treatment‐naïve (TransF_naïve), and 10 transfeminine treatment‐ongoing (TransF_ongoing) were examined at baseline and after 1 year of GAHT. Primary outcomes were unilateral upper body maximal muscle strength (kg) and mean and maximal power (watt) measured by low‐row dynamic testing. Dual‐energy X‐ray absorptiometry was conducted in all participants.

Results

In transmasculine persons, the median (quartiles) age was 22 (20; 30) years in TransM_naïve and 26 (22–29) years in TransM_ongoing (median GAHT duration 3 (2; 5) years) at study inclusion. Maximal muscle strength increased 6.3 kg (12%) in TransM_naïve ( p ≤ 0.001) and 5.0 kg (7%) in TransM_ongoing ( p ≤ 0.001), while maximal muscle power remained unchanged. ∆‐muscle strength was positively associated with ∆‐lean mass in arms and negatively associated with age at GAHT initiation. In transfeminine persons, the median age was 24 (22; 30) years in TransF_naïve and 40 (31–64) years in TransF_ongoing (median GAHT duration 4 (2; 6) years) at study inclusion. Maximal muscle strength decreased 17.5 kg (23%) in TransF_naïve and ‐5.0 kg (8%) in TransF_ongoing, which was accompanied by a decrease (23%) in maximal muscle power in TransF_naïve.

Conclusion

Upper body muscle strength but not power increased during masculinizing GAHT, whereas muscle strength and power decreased within the first year of feminizing GAHT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle StrengthTransgender PersonsHumansFemaleMaleProspective StudiesAdultYoung AdultMuscle, Skeletal

Stichwörter der Autor:innen

gender‐affirming hormone therapymuscle powermuscle strengthtransgender persons

Autor:innen und Institutionen

  • Department of Endocrinology, Odense University Hospital, Odense, Denmark.
  • Department of Sports Science and Clinical Biomechanics, Muscle Physiology and Biomechanics Research Unit, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Research, Geriatric Research Unit, University of Southern Denmark, Odense, Denmark.
  • Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark.

ORCID-Profile: Louise Lehmann Christensen

Förderung

  • Body Identity Clinic (BIC) Frontline Center Odense University Hospital
  • Pre-graduate Fund Odense University Hospital
  • Danish Research Council
  • Region of Southern Denmark
  • Danish Health Authority and Novo Nordisk Foundation
  • Danish Diabetes and Endocrine Academy (DDEA)

Zitieren

APA

Nørlund, M. K., Nielsen, J. L., Andersen, M. S., Hjortebjerg, R., Buhl, L. F., Hermann, A. P., Palm, C. V. B., Kristensen, T. T., Frystyk, J., Aagaard, P., Mathiesen, J., Glintborg, D., & Christensen, L. L. (2026). Muscle Strength and Power Changes With Gender‐Affirming Hormone Therapy. Andrology, 14(7), 2138-2149. https://doi.org/10.1111/andr.70132

Vancouver

Nørlund MK, Nielsen JL, Andersen MS, Hjortebjerg R, Buhl LF, Hermann AP, et al. Muscle Strength and Power Changes With Gender‐Affirming Hormone Therapy. Andrology. 2026;14(7):2138-2149. doi:10.1111/andr.70132

BibTeX
@article{Nrlund2026,
  author = {Nørlund, Mathilde Kamp and Nielsen, Jakob Lindberg and Andersen, Marianne Skovsager and Hjortebjerg, Rikke and Buhl, Laust Frisenberg and Hermann, Anne Pernille and Palm, Camilla Viola Buskbjerg and Kristensen, Tine Taulbjerg and Frystyk, Jan and Aagaard, Per and Mathiesen, Jonas and Glintborg, Dorte and Christensen, Louise Lehmann},
  title = {Muscle Strength and Power Changes With Gender‐Affirming Hormone Therapy},
  journal = {Andrology},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {2138--2149},
  doi = {10.1111/andr.70132}
}
Kostenlos starten →